{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-24-000120","form_type":"8-K","ticker":"RVTY","cik":"0000031791","company_name":"REVVITY, INC.","filed_at":"2024-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.550805+00:00","generated_at":"2026-06-06T16:46:23.007871+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Revvity elects two new directors; Dr. Sylvie Grégoire not seeking re-election","bullets":["Dr. Sylvie Grégoire not standing for re-election at the 2024 annual meeting on Apr 23; no disagreement with company.","Board elected Michael A. Klobuchar and Sophie V. Vandebroek as directors, effective Feb 1, 2024.","New directors receive prorated annual equity ($22,500 stock + $27,500 RSU) and prorated cash retainer of $90,000.","Neither Klobuchar nor Vandebroek will initially serve on a board committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-24-000120","json":"https://secwatch.observer/filing/0001157523-24-000120.json","markdown":"https://secwatch.observer/filing/0001157523-24-000120.md","text":"https://secwatch.observer/filing/0001157523-24-000120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/31791/000115752324000120/0001157523-24-000120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/31791/000115752324000120/a53887562.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T16:46:23.007871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02e70ca2ad","claim":"Sophie V. Vandebroek was elected as Director at REVVITY, INC..","evidence_excerpt":"On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/31791/000115752324000120/0001157523-24-000120-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f4900279c9","claim":"Michael A. Klobuchar was elected as Director at REVVITY, INC..","evidence_excerpt":"On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/31791/000115752324000120/0001157523-24-000120-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fc226aa82e","claim":"Dr. Sylvie Grégoire departed as Director at REVVITY, INC..","evidence_excerpt":"On January 25, 2024, Dr. Sylvie Grégoire, a member of the Board of Directors (the “Board”) of Revvity, Inc. (“Revvity” or the “Company”) notified the Company of her decision not to stand for re-election to the Board at the annual meeting of shareholders of the Company scheduled to occur on April 23, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/31791/000115752324000120/0001157523-24-000120-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}